Patients with VAP in RICU PatientsNCT06640374
Role of Clinical Pulmonary Infection Score and Sonopulmonary Infection Score in Diagnosis and Predicting Outcome of VAP in RUCU
An observational study of Patients with VAP in RICU Patients, run by Assiut University.
Trial summary
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patients with VAP in RICU Patients
- How many people
- 70 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2024to 30 Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with VAP Patients who don't develop VAP
Who may be able to join
- Patient 18 yrs or more Mechanically ventilated patients after 48 hrs after admission of ICU
Who cannot join
- Patient less than 18 yrs Patients diagnosed as pneumonia
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively
The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:
community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
Read the detailed description
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively
The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:
community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
- Conditions
- Patients with VAP in RICU Patients
What is being measured
The primary outcome is the main question the study is designed to answer.
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Diagnosis of VAP in RICU Patients
Measured: 4 years
Secondary outcomes (1)
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Diagnosis of VAP in RICU PATIENTS
Measured: 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start1 Nov 2024 (estimated)
- Primary completion19 Sep 2025 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Patients with VAP in RICU PatientsStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa khaled, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06640374
- Sponsor's protocol ID
- Assiit University
- Status last verified
- Oct 2024
- First submitted
- 11 Oct 2024
- Last updated
- 15 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
Publications
Reissig A, Copetti R, Kroegel C. Current role of emergency ultrasound of the chest. Crit Care Med. 2011 Apr;39(4):839-45. doi: 10.1097/CCM.0b013e318206d6b8.
PubMed 21263325Naranje P, Bhalla AS, Sherwani P. Chest Tuberculosis in Children. Indian J Pediatr. 2019 May;86(5):448-458. doi: 10.1007/s12098-018-02847-7. Epub 2019 Feb 14.
PubMed 30762202
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Clinical Pulmonary Infection Score and Sonopulmonary Infection Score in Diagnosis and Predicting Outcome of VAP in RUCU
- ClinicalTrials.gov ID
- NCT06640374
- Acronym / sponsor ID
- Assiit University
- Conditions
- Patients with VAP in RICU Patients
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Nov 2024 (estimated)
- Primary completion
- 19 Sep 2025 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 15 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively
The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:
community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
Detailed description
-Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively
The classification scheme for pneumonia in UK NHS hospitals is based on the setting in which the infection was mostly likely acquired:
community-acquired pneumonia (CAP), when a patient is in the hospital <48h before the pneumonia is suspected; hospital-acquired pneumonia (HAP), when a patient is in the hospital >48h before the pneumonia develops, but is not associated with mechanical ventilation; and ventilator-associated pneumonia (VAP), when a patient is mechanically ventilated and intubated for >48h before the pneumonia develops The causative pathogens in each scenario are different, and treatment strategies vary as a consequence.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with VAP Patients who don't develop VAP
Key inclusion criteria (1 listed)
- Patient 18 yrs or more Mechanically ventilated patients after 48 hrs after admission of ICU
Key exclusion criteria (1 listed)
- Patient less than 18 yrs Patients diagnosed as pneumonia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Time frame: 4 years
Diagnosis of VAP in RICU Patients
1 secondary outcome
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients
Time frame: 4 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2024.
- Background: PubMed 21263325Reissig A, Copetti R, Kroegel C. Current role of emergency ultrasound of the chest. Crit Care Med. 2011 Apr;39(4):839-45. doi: 10.1097/CCM.0b013e318206d6b8.
- Background: PubMed 30762202Naranje P, Bhalla AS, Sherwani P. Chest Tuberculosis in Children. Indian J Pediatr. 2019 May;86(5):448-458. doi: 10.1007/s12098-018-02847-7. Epub 2019 Feb 14.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Patients with VAP in RICU Patients, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 15 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Esraa Khaled Abo hossiba, Resident doctor (01126914592, ee297700@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Role of Clinical Pulmonary Infection Score and sonopulmonary infection score in diagnosis of VAP and Predicting Outcome in RICU Patients (time frame: 4 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06640374, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2024.